Showing results (2241-2250 of 2,350) with videos related to

Sort By:
Pageof 235
Blood|May 1, 1997
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patientsZ X Shen, G Q Chen, J H Ni, et al.
Oral Oncology|November 2, 2025
Sensitivity of post-treatment surveillance in detecting recurrence and metastasis in surgically treated HPV-positive oropharyngeal squamous cell carcinoma patientsAgnes Q Zhu, Claire E Cassianni, Travis Haller, et al.
Zhonghua Nei Ke Za Zhi|December 6, 2016
[A cross-section study of severe asthma in eight provinces of China]N Su, J T Lin, W Y Wang, et al.
Physical Review Letters|April 7, 2010
Enhancement of photon number reflected by the relativistic flying mirrorM Kando, A S Pirozhkov, K Kawase, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|March 28, 2020
[Risk assessment and early warning of imported COVID-19 in Guangdong province]J X Hu, T Liu, J P Xiao, et al.
Blood|August 1, 1996
In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteinsG Q Chen, J Zhu, X G Shi, et al.
Nucleic Acids Research|February 11, 2025
Biomolecular condensation of human IDRs initiates endogenous transcription via intrachromosomal looping or high-density promoter localizationJing Li, Shizhe Liu, Sunghwan Kim, et al.
Nucleic Acids Research|February 19, 2025
Biomolecular condensation of human IDRs initiates endogenous transcription via intrachromosomal looping or high-density promoter localizationJing Li, Shizhe Liu, Sunghwan Kim, et al.
Oral Oncology|January 11, 2024
Association Between Social Determinants of Health, Distance from Treatment Center, and Treatment Type with Outcomes in Human Papillomavirus Associated Oropharyngeal cancerAisha A Aden, Felicia O Olawuni, Chadi N Abdel-Halim, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 25, 2023
[Efficacy and safety of bendamustine-rituximab combination therapy for newly diagnosed indolent B-cell non-Hodgkin's lymphoma and elderly mantle cell lymphoma: a multi-center prospective phase II clinical trial in China]H Wang, Q He, D Liu, et al.
Pageof 235